These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 22963554

  • 1. Development of new drugs for COPD.
    Barnes PJ.
    Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
    [Abstract] [Full Text] [Related]

  • 2. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ.
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [Abstract] [Full Text] [Related]

  • 3. Emerging pharmacotherapies for COPD.
    Barnes PJ.
    Chest; 2008 Dec; 134(6):1278-1286. PubMed ID: 19059958
    [Abstract] [Full Text] [Related]

  • 4. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
    Barnes PJ.
    Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638
    [Abstract] [Full Text] [Related]

  • 5. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ.
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction.
    Hakim A, Adcock IM, Usmani OS.
    Drugs; 2012 Jul 09; 72(10):1299-312. PubMed ID: 22731962
    [Abstract] [Full Text] [Related]

  • 7. New treatments for COPD.
    Ngkelo A, Adcock IM.
    Curr Opin Pharmacol; 2013 Jun 09; 13(3):362-9. PubMed ID: 23602653
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
    Barnes PJ.
    J Allergy Clin Immunol; 2015 Sep 09; 136(3):531-45. PubMed ID: 26343937
    [Abstract] [Full Text] [Related]

  • 9. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease.
    Jiang Z, Zhu L.
    Pulm Pharmacol Ther; 2016 Apr 09; 37():1-8. PubMed ID: 26805715
    [Abstract] [Full Text] [Related]

  • 10. New anti-inflammatory targets for chronic obstructive pulmonary disease.
    Barnes PJ.
    Nat Rev Drug Discov; 2013 Jul 09; 12(7):543-59. PubMed ID: 23977698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG, Calzetta L, Segreti A, Cazzola M.
    Expert Opin Emerg Drugs; 2012 Mar 09; 17(1):61-82. PubMed ID: 22335427
    [Abstract] [Full Text] [Related]

  • 13. COPD: is there light at the end of the tunnel?
    Barnes PJ.
    Curr Opin Pharmacol; 2004 Jun 09; 4(3):263-72. PubMed ID: 15140418
    [Abstract] [Full Text] [Related]

  • 14. Positioning new pharmacotherapies for COPD.
    Barjaktarevic IZ, Arredondo AF, Cooper CB.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 09; 10():1427-42. PubMed ID: 26244017
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA, Donohue JF.
    Proc Am Thorac Soc; 2007 Oct 01; 4(7):526-34. PubMed ID: 17878465
    [Abstract] [Full Text] [Related]

  • 16. Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).
    Ti H, Zhou Y, Liang X, Li R, Ding K, Zhao X.
    J Med Chem; 2019 Jul 11; 62(13):5944-5978. PubMed ID: 30682248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.